429687-52-5

Upstream product

• 429687-44-5 (S)-2-[4-(tert-butyldimethylsilyloxy)-1-butyl]oxirane 
• 249764-10-1 {1-[5-(tert-butyl-dimethyl-silanyloxy)-2,4-dimethoxy-3-methyl-benzyl]-2-cyano-2-hydroxy-ethyl}-carbamic acid 9H-fluoren-9-ylmethyl ester 
• 429687-49-0 (S)-2-[4-(tert-butyldimethylsiloxy)-1-butyl]morpholine 
• 249764-06-5 {2-[5-(tert-butyl-dimethyl-silanyloxy)-2,4-dimethoxy-3-methyl-phenyl]-1-formyl-ethyl}-carbamic acid 9H-fluoren-9-ylmethyl ester 
• 103791-53-3 rac-tert-butyl-dimethyl-(4-oxiranyl-butoxy)-silane 
• 85807-84-7 tert-butyl(5-hexenyloxy)dimethylsilane 
• 821-41-0 5-Hexen-1-ol 
• 429687-47-8 1-[benzyl-(2-hydroxy-ethyl)-amino]-6-(tert-butyl-dimethyl-silanyloxy)-hexan-2-ol 
• 429687-46-7 6-(tert-butyl-dimethyl-silanyloxy)-1-(2-hydroxy-ethylamino)-hexan-2-ol 
• 477566-53-3 {2-{2-[4-(tert-butyl-dimethyl-silanyloxy)-butyl]-morpholin-4-yl}-1-[5-(tert-butyl-dimethyl-silanyloxy)-2,4-dimethoxy-3-methyl-benzyl]-2-cyano-ethyl}-carbamic acid 9H-fluoren-9-ylmethyl ester 

Relevant academic research and scientific papers

A solid-supported, enantioselective synthesis suitable for the rapid preparation of large numbers of diverse structural analogues of (-)-saframycin A

A 10-step solid-supported, enantioselective synthesis suitable for the rapid preparation of large numbers of diverse structural analogues of saframycin A is described. The synthetic route, which bears analogy to solid-phase peptide synthesis, involves the